Presented encouraging preclinical data for INB-619, a CD19-targeting γδ T cell engager for oncology and autoimmune diseases. The data showed complete B cell depletion, robust γδ T cell expansion, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results